Hospira (NYSE:HSP) will report earnings before markets open on Wednesday, May 1st. Hospira, Inc. is a global specialty pharmaceutical and medication delivery company. The Company’s product portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems.
Here is your Cheat Sheet to Hospira Earnings:
Earnings Expectations: Analysts expect earnings of $0.44 per share on revenues of $979.33 million. Currently, the company’s P/E ratio stands at 118.36.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.6 to a profit $0.51. For the current year, the average estimate is a profit of $2.03, which is worse than the estimate ninety days ago.
Here’s how Hospira has been performing on an annual basis:
|Revenue ($) in millions||3,630||3,879||3,917||4,057||4,092|
|Diluted EPS ($)||1.99||2.47||2.11||-0.06||0.27|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||1,014||965.90||1,033||994.00||1,099|
|Diluted EPS ($)||-1.300||0.24||-0.02||0.01||0.0319|
Hospira has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)